Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • New2Bioinfo
    Junior Member
    • Dec 2016
    • 4

    Indexing- Exons and splice sites

    Hi,
    I have been following the github tutorial, https://github.com/griffithlab/rnaseq_tutorial/wiki

    to learn RNAseq.

    I was on the indexing step and it says to first export exons and splice sites from reference genome using in-built python scripts before starting the indexing. And then that this information will be used during alignment.

    It would be great if someone could explain the rationale behind this step.
    ----
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Sometimes if you are happy with the current state of the transcriptome (known expressed parts of the genome) then you could choose to do alignments of your data just to that part.

    While that is not incorrect, you do run a small risk of having some reads mis-align (since an aligner does its best to align and the read may not have originally come from that region) by restricting to just "known" expressed parts of the genome. If splice sites are provided as well then the programs would not try to look for new ones. Both these modifications speed up the alignments to some extent.

    Comment

    • New2Bioinfo
      Junior Member
      • Dec 2016
      • 4

      #3
      Originally posted by GenoMax View Post
      Both these modifications speed up the alignments to some extent.
      That's okay. But while using the HISAT2 program, I am extracting the splice site and exon information from the .gtf file. And that information is given to the index builder (Hisat2-build). So, what I am getting is that this information during indexing is helping during alignment.

      If I know the splice sites, the reads will not align to those parts where splice sites lie in the middle. Is this correct?
      I still don't get how exon info is helping in alignment.

      A little more detailed answer would be really really helpful.

      Thank you.
      ----

      Comment

      • wdecoster
        Member
        • Oct 2015
        • 97

        #4
        The most intuitive explanation might be that those "known" exons and splice sites are used as a suggestion for the read mapping, making mapping much quicker since the aligner "knows" where to look. Reads that don't behave according to the "known" annotation will still get correctly aligned and new splice sites will be discovered.

        You are just "telling" the aligner a priori where the splice junctions most likely are (but not restricting the mapping to those junctions/exons).

        Comment

        • New2Bioinfo
          Junior Member
          • Dec 2016
          • 4

          #5
          Okay. That makes sense.

          Thank you very much.
          ----

          Comment

          • biocomputer
            Member
            • Dec 2013
            • 62

            #6
            Does including exons and splice sites make the alignment more accurate, faster, or both?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              Today, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 11:10 AM
            0 responses
            8 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            25 views
            0 reactions
            Last Post SEQadmin2  
            Working...